Literature DB >> 25163501

Biological function of activation-induced cytidine deaminase (AID).

Ritu Kumar, Lauren J DiMenna, Jayanta Chaudhuri1, Todd Evans2.   

Abstract

Activation-induced Cytidine Deaminase (AID) is an essential regulator of B cell diversification, but its full range of action has until recently been an enigma. Based on homology, it was originally proposed to be an RNA-editing enzyme, but so far, no RNA substrates are known. Rather, it functions by deaminating cytidine, and in this manner, coupled with base-excision repair or mismatch repair machinery, it is a natural mutator. This allows it to play a central role in adaptive immunity, whereby it initiates the processes of class switch recombination and somatic hypermutation to help generate a diverse and high-affinity repertoire of immunoglobulin isotypes. More recently, it has been appreciated that methylated cytidine, already known as a key epigenetic mark on DNA controlling gene expression, can also be a target for AID modification. Coupled with repair machinery, this can facilitate the active removal of methylated DNA. This activity can impact the process of cellular reprogramming, including transition of a somatic cell to pluripotency, which requires major reshuffling of epigenetic memory. Thus, seemingly disparate roles for AID in controlling immune diversity and epigenetic memory have a common mechanistic basis. However, the very activity that is so useful for B cell diversity and cellular reprogramming is dangerous for the integrity of the genome. Thus, AID expression and activity is tightly regulated, and deregulation is associated with diseases including cancer. Here, we review the range of AID functions with a focus on its mechanisms of action and regulation. Major questions remain to be answered concerning how and when AID is targeted to specific loci and how this impacts development and disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25163501     DOI: 10.4103/2319-4170.128734

Source DB:  PubMed          Journal:  Biomed J        ISSN: 2319-4170            Impact factor:   4.910


  12 in total

Review 1.  The Emerging Role of Cytidine Deaminase in Human Diseases: A New Opportunity for Therapy?

Authors:  Audrey Frances; Pierre Cordelier
Journal:  Mol Ther       Date:  2019-12-06       Impact factor: 11.454

2.  Bacteria deplete deoxynucleotides to defend against bacteriophage infection.

Authors:  Nitzan Tal; Adi Millman; Avigail Stokar-Avihail; Taya Fedorenko; Azita Leavitt; Sarah Melamed; Erez Yirmiya; Carmel Avraham; Alexander Brandis; Tevie Mehlman; Gil Amitai; Rotem Sorek
Journal:  Nat Microbiol       Date:  2022-07-11       Impact factor: 30.964

Review 3.  Epigenetic function of activation-induced cytidine deaminase and its link to lymphomagenesis.

Authors:  Pilar M Dominguez; Rita Shaknovich
Journal:  Front Immunol       Date:  2014-12-18       Impact factor: 7.561

4.  Mutations in human AID differentially affect its ability to deaminate cytidine and 5-methylcytidine in ssDNA substrates in vitro.

Authors:  Lucyna Budzko; Paulina Jackowiak; Karol Kamel; Joanna Sarzynska; Janusz M Bujnicki; Marek Figlerowicz
Journal:  Sci Rep       Date:  2017-06-20       Impact factor: 4.379

5.  Mesenteric CD103+DCs Initiate Switched Coxsackievirus B3 VP1-Specific IgA Response to Intranasal Chitosan-DNA Vaccine Through Secreting BAFF/IL-6 and Promoting Th17/Tfh Differentiation.

Authors:  Haoxin Zhao; Jie Yang; Qian Qian; Manli Wu; Min Li; Wei Xu
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

6.  Relevance of PSGL-1 Expression in B Cell Development and Activation.

Authors:  Rafael González-Tajuelo; Elena González-Sánchez; Javier Silván; Antonio Muñoz-Callejas; Esther Vicente-Rabaneda; Javier García-Pérez; Santos Castañeda; Ana Urzainqui
Journal:  Front Immunol       Date:  2020-11-12       Impact factor: 7.561

7.  Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia.

Authors:  Kristina Zaprazna; Kamila Reblova; Veronika Svobodova; Lenka Radova; Vojtech Bystry; Jiri Baloun; Kristina Durechova; Nikola Tom; Tomas Loja; Martina Buresova; Kamila Stranska; Alexandra Oltova; Michael Doubek; Michael L Atchison; Martin Trbusek; Jitka Malcikova; Sarka Pospisilova
Journal:  Ann Hematol       Date:  2018-10-27       Impact factor: 3.673

Review 8.  AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression.

Authors:  Pablo Oppezzo; Marcelo Navarrete; Nicholas Chiorazzi
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

9.  Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma.

Authors:  Aniruddha Chatterjee; Euan J Rodger; Antonio Ahn; Peter A Stockwell; Matthew Parry; Jyoti Motwani; Stuart J Gallagher; Elena Shklovskaya; Jessamy Tiffen; Michael R Eccles; Peter Hersey
Journal:  iScience       Date:  2018-06-28

Review 10.  Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity.

Authors:  Georgios Sogkas; Faranaz Atschekzei; Ignatius Ryan Adriawan; Natalia Dubrowinskaja; Torsten Witte; Reinhold Ernst Schmidt
Journal:  Cell Mol Immunol       Date:  2021-04-01       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.